141 related articles for article (PubMed ID: 17680883)
41. Nigral burden of alpha-synuclein correlates with striatal dopamine deficit.
Kovacs GG; Milenkovic IJ; Preusser M; Budka H
Mov Disord; 2008 Aug; 23(11):1608-12. PubMed ID: 18649394
[TBL] [Abstract][Full Text] [Related]
42. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
Manning-Boğ AB; Caudle WM; Perez XA; Reaney SH; Paletzki R; Isla MZ; Chou VP; McCormack AL; Miller GW; Langston JW; Gerfen CR; Dimonte DA
Neurobiol Dis; 2007 Aug; 27(2):141-50. PubMed ID: 17560790
[TBL] [Abstract][Full Text] [Related]
43. Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
Bianco LE; Wiesinger J; Earley CJ; Jones BC; Beard JL
J Neurochem; 2008 Jul; 106(1):205-15. PubMed ID: 18363828
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid.
Grintal B; Champeil-Potokar G; Lavialle M; Vancassel S; Breton S; Denis I
Neurochem Int; 2009 Jul; 54(8):535-43. PubMed ID: 19428799
[TBL] [Abstract][Full Text] [Related]
45. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.
Thompson LH; Grealish S; Kirik D; Björklund A
Eur J Neurosci; 2009 Aug; 30(4):625-38. PubMed ID: 19674082
[TBL] [Abstract][Full Text] [Related]
46. Unconventional effects of estrogen uncovered.
Dluzen DE
Trends Pharmacol Sci; 2005 Oct; 26(10):485-7. PubMed ID: 16122814
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the neuronal dopamine transporter DAT in human blood platelets.
Frankhauser P; Grimmer Y; Bugert P; Deuschle M; Schmidt M; Schloss P
Neurosci Lett; 2006 May; 399(3):197-201. PubMed ID: 16490314
[TBL] [Abstract][Full Text] [Related]
48. Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.
Julku UH; Panhelainen AE; Tiilikainen SE; Svarcbahs R; Tammimäki AE; Piepponen TP; Savolainen MH; Myöhänen TT
Mol Neurobiol; 2018 Jan; 55(1):470-482. PubMed ID: 27966077
[TBL] [Abstract][Full Text] [Related]
49. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease.
Miller RM; Kiser GL; Kaysser-Kranich TM; Lockner RJ; Palaniappan C; Federoff HJ
Neurobiol Dis; 2006 Feb; 21(2):305-13. PubMed ID: 16143538
[TBL] [Abstract][Full Text] [Related]
50. The intrastriatal injection of thrombin in rat induced a retrograde apoptotic degeneration of nigral dopaminergic neurons through synaptic elimination.
Herrera AJ; de Pablos RM; Carreño-Müller E; Villarán RF; Venero JL; Tomás-Camardiel M; Cano J; Machado A
J Neurochem; 2008 May; 105(3):750-62. PubMed ID: 18179476
[TBL] [Abstract][Full Text] [Related]
51. Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures.
Luo X; Zhang X; Shao W; Yin Y; Zhou J
J Neurochem; 2009 Feb; 108(4):952-61. PubMed ID: 19196427
[TBL] [Abstract][Full Text] [Related]
52. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
53. Dopamine transporter immunoreactive terminals in the bovine pineal gland.
Phansuwan-Pujito P; Boontem P; Chetsawang B; Ebadi M; Govitrapong P
Neurosci Lett; 2006 Jul; 403(1-2):78-83. PubMed ID: 16781060
[TBL] [Abstract][Full Text] [Related]
54. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
Aoki E; Yano R; Yokoyama H; Kato H; Araki T
Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
[TBL] [Abstract][Full Text] [Related]
55. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
Sedaghat K; Finkelstein DI; Gundlach AL
Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
[TBL] [Abstract][Full Text] [Related]
56. Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study.
Han S; Feng Y; Guo M; Hao Y; Sun J; Zhao Y; Dong Q; Zhao Y; Cui M
Environ Health Perspect; 2022 May; 130(5):57004. PubMed ID: 35511227
[TBL] [Abstract][Full Text] [Related]
57. Oestrogen effects on dopaminergic function in striatum.
Becker JB
Novartis Found Symp; 2000; 230():134-45; discussion 145-54. PubMed ID: 10965506
[TBL] [Abstract][Full Text] [Related]
58. Dopamine regulates the expression of the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes.
Brito VI; Rozanski VE; Beyer C; Küppers E
J Mol Neurosci; 2009 Nov; 39(3):372-9. PubMed ID: 19685014
[TBL] [Abstract][Full Text] [Related]
59. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
Nagel F; Falkenburger BH; Tönges L; Kowsky S; Pöppelmeyer C; Schulz JB; Bähr M; Dietz GP
J Neurochem; 2008 May; 105(3):853-64. PubMed ID: 18182047
[TBL] [Abstract][Full Text] [Related]
60. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
